We save babies before they are born
Fetal surgery – operating on babies while still in their mother’s womb – is a medical breakthrough in the treatment of babies with life-threatening conditions. However, these life-saving surgeries are associated with a high rate of pre-term birth. KOVE is developing an innovative implantable medical device to make these surgeries safe, preventing the risk of preterm birth while unleashing the potential of fetal surgery.
KOVE is the result of fruitful academic research at the University Hospital of Zürich in collaboration with leading surgeons in the field of fetal surgery. The company is now in pre-clinical phase and has been awarded multiple translational grants (BioEntrepreneur Fellowship, Gebert Rüf Foundation, Bridge, Venture Kick).
The team is currently composed by: